A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

NCT02265393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniere's Disease

Interventions

DRUG: OTO-104
DRUG: Placebo

Sponsor

Otonomy, Inc.